1. Home
  2. DCOY vs STKH Comparison

DCOY vs STKH Comparison

Compare DCOY & STKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Decoy Therapeutics Inc. Common Stock

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$1.10

Market Cap

674.8K

Sector

Health Care

ML Signal

N/A

Logo Steakholder Foods Ltd.

STKH

Steakholder Foods Ltd.

N/A

Current Price

$0.39

Market Cap

566.1K

ML Signal

N/A

Company Overview

Basic Information
Metric
DCOY
STKH
Founded
N/A
2018
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
674.8K
566.1K
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
DCOY
STKH
Price
$1.10
$0.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
74.1K
★ 1.0M
Earning Date
11-16-2026
08-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$20.42
$218.44
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.30
52 Week High
$67.68
$7.10

Technical Indicators

Market Signals
Indicator
DCOY
STKH
Relative Strength Index (RSI) 33.76 25.32
Support Level $0.53 $0.36
Resistance Level $3.29 $0.64
Average True Range (ATR) 0.11 0.07
MACD 0.06 0.05
Stochastic Oscillator 32.71 32.41

Price Performance

Historical Comparison
DCOY
STKH

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industry through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures, such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

Share on Social Networks: